BiotechTube
Home/Reglagene/Richard Austin, PhD, MBA
RA

Richard Austin, PhD, MBA

Chief Executive Officer/President

Reglagene

Therapeutic Areas

OncologyNeurology

Reglagene Pipeline

DrugIndicationPhase
RGN6024Brain Cancers (e.g., Glioblastoma)Pre-clinical

Leadership Team at Reglagene

VG
Vijay Gokhale, PhD
Senior Vice President, Preclinical Development
LH
Laurence Hurley, PhD
Director, Co-Founder
LK
Lawrence Kinet, MBA
Board Chair
View full Reglagene profile